Exendin 4: AC 2993, AC 2993 LAR

By  

BioDrugs, Vol. 16, Iss. 3, 2002-01 ,pp. : 220-222

Adis International

Access to resources Recommend Favorite

Pramlintide in the Treatment of Diabetes Mellitus

By Edelman Steve  

BioDrugs, Vol. 22, Iss. 6, 2008-01 ,pp. : 375-386

Adis International

Access to resources Recommend Favorite

Serum opsonic and bactericidal activity after Neisseria meningitidis group A+C and Haemophilus influenzae type b vaccination: a comparison of three functional assays

By Hugosson S.   Fredlund H.   Kayhty H.   Olcen P.  

Serodiagnosis and Immunotherapy in Infectious Disease, Vol. 8, Iss. 3, 1997-01 ,pp. : 213-220

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of Human Amylin Analogues in Diabetes Mellitus

By Cooper G.J.S.  

BioDrugs, Vol. 10, Iss. 1, 1998-07 ,pp. : 1-9

Adis International

Access to resources Recommend Favorite

Evidence-Based Regulation- A Personal View; Volume 6: 137 (2002). ; Gene Therapy Coming of Age in Latin America; Volume 6: 153-154 (2002). ; Development and Optimization of a Real-Time Quantitative PCR-Based Method for the Titration of AAV-2 Vector Stocks; Volume 6: 272-278 (2002).

By Brenner M.   Podhajcer O.   Pitossi F.   Aguilar-Cordova E.   Veldwijk M.R.   Topaly J.   Laufs S.   Hengge U.R.   Wenz F.   Zeller W.J.   Fruehauf S.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 429-429

Elsevier

Access to resources Recommend Favorite